Newsroom

PHILADELPHIA--(BUSINESS WIRE)--FORE Biotherapeutics, a registration stage company dedicated to developing targeted therapies to treat patients with cancer, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to plixorafenib for the treatment of adult patients with BRAF V600E-mutated high-grade glioma (HGG). Fore Bio believes this is the first BTD granted to a targeted therapy for HGG. Plixorafenib is a novel BRAF inhibitor that is...

HOUSTON--(BUSINESS WIRE)--Expro Group Holdings N.V. (NYSE: XPRO) (the “Company” or “Expro”) today announced the Company’s Board of Directors (the “Board”) has unanimously approved a plan to change the Company’s corporate domicile from the Netherlands to the Cayman Islands (the “Redomicile”). The Company and the Board believe that the Redomicile will promote the sustainable success of its business, taking into account the interests of its shareholders and other stakeholders, and will enhance sha...

LONDEN--(BUSINESS WIRE)--The AI Summit London, de conferentie waar commerciële AI tot leven komt, heeft strategische samenwerkingen aangekondigd met de London Business School en General Purpose om twee specifieke AI Training-programma's voor te stellen, die op 9 juni doorgaan in aanloop op de conferentie. Gebaseerd op de wereldwijd erkende expertise in opleidingen voor executives van de DSAI (Data Science & AI Initiative) aan de London Business School, is de eendaagse AI Leadership Accelera...

OLDWICK, N.J.--(BUSINESS WIRE)--AM Best has affirmed the Financial Strength Rating (FSR) of A+ (Superior) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of “aa-” (Superior) of the members of Metropolitan Life Insurance Group (collectively referred to as MetLife or the group). Concurrently, AM Best has affirmed the Long-Term ICR of “a-” (Excellent) and the Long- and Short-Term Issue Credit Ratings (Long-Term IR; Short-Term IR) of MetLife, Inc. (headquartered in New York, NY) [NYSE: MET]...

TORONTO--(BUSINESS WIRE)--RioCan Real Estate Investment Trust (“RioCan”) (TSX: REI.UN) today announced that it is scheduled to release its financial and operational results for the three months ended March 31, 2026, after the market closes on Monday, May 4, 2026. Interested parties are invited to participate in a conference call with management on Tuesday, May 5, 2026 at 10:00 a.m. Eastern time. To access the conference call, participants are encouraged to pre‑register using the Pre-registratio...

MINNEAPOLIS--(BUSINESS WIRE)--On Thursday, April 30, 2026, Xcel Energy (NASDAQ: XEL) will host a conference call to review first quarter 2026 financial results. The earnings report will be released prior to the market open on the same date. The call will begin at 9:00 a.m. Central Time. To participate in the conference call, please dial in at least 10 minutes prior to the scheduled start and follow the operator’s instructions. U.S. Toll-Free Dial-In: 1-800-715-9871 U.S. / International Toll Dia...

BEIJING--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), een internationaal biotechnologiebedrijf dat R&D bevordert voor nieuwe geneesmiddelen op basis van antilichamen met innovatieve technologieën, kondigde vandaag een strategisch partnerschap aan met Sihuan Pharmaceutical Holdings Group Ltd. (Sihuan Pharmaceutical; HKEX: 00460). In het kader van de overeenkomst zullen beide partijen het toonaangevende platform van Biocytogen voor de...

PÉKIN--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE : 688796 ; HKEX : 02315), une biotech mondiale qui stimule la R&D de nouveaux médicaments à base d'anticorps grâce à des technologies innovantes, annonce aujourd'hui un partenariat stratégique avec Sihuan Pharmaceutical Holdings Group Ltd. (Sihuan Pharmaceutical ; HKEX : 00460). En vertu de l’accord, les deux parties combineront la principale plateforme de découverte d’anticorps entièrement humains de Bi...

PECHINO--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), azienda biotecnologica globale promotrice della ricerca e dello sviluppo di nuovi farmaci a base anticorpale grazie a tecnologie innovative, oggi ha annunciato una collaborazione strategica con Sihuan Pharmaceutical Holdings Group Ltd. (Sihuan Pharmaceutical; HKEX: 00460). In base ai termini dell'accordo, le due parti integreranno la piattaforma leader nella scoperta di anticorpi com...

LINCOLN, Neb.--(BUSINESS WIRE)--Dormie Network has announced plans to build a new clubhouse at Victoria National in Newburgh, Indiana. The project represents Dormie Network’s continued commitment to enhancing the member experience, ensuring facilities match the caliber of a golf course ranked the No. 1 Best Course in Indiana by Golf Digest. "Victoria National has come a long way since Dormie Network acquired it in 2018,” says Victoria National General Manager Brad Wilson. “As a Top 100 course i...